 |
The Institute receives financial support from both the McGovern Foundation and MIT. The Board of Directors contains representatives appointed by the McGovern family and MIT, as well as renowned scientists outside of MIT. The McGovern Institute is also guided by a distinguished Scientific Advisory Board composed of some of the world's most prominent neurobiologists. The Institute operates as a full member of the MIT community, conforming to all MIT policies regarding faculty, students, staff, and personnel. All faculty appointments to the McGovern Institute are approved by MIT, and all faculty members have appointments in MIT departments. The McGovern Institute's novel administrative structure accomplishes twin objectives of the institute: developing an intensive program of advanced research within its walls, as well as engaging and enhancing the neuroscience community at MIT.
Administration
The Director of the McGovern Institute is Robert Desimone, an internationally known neuropsychologist. Dr. Desimone's research explores the brain mechanisms underlying attention, memory and executive control. Prior to joining the McGovern Institute, he directed the NIMH Intramural Research Program, the largest mental health research center in the world.
- Robert Desimone, Ph.D., Director
- Charles Jennings, Ph.D., Director McGovern Institute Neurotechnology Program
- Shannon Landerer, Administrative Assistant
- Laurie Ledeen, Development and Special Projects Officer
- Gayle Lutchen, Assistant Director for Administration
- Donna Wells, Financial Officer
- Emily Wilkoff, Financial Assistant
Board of Directors
- Patrick McGovern
- Lore Harp McGovern
- Elizabeth McGovern
- Gerald Fischbach, Columbia University
- Marc Kastner, Massachusetts Institute of Technology
- Robert Langer, Massachusetts Institute of Technology
- Edward Scolnick, Broad Institute
- Sheila Widnall, Massachusetts Institute of Technology
- Torsten Wiesel, Rockefeller University
Scientific Advisory Board
- John Duncan, MRC Cognition and Brain Sciences Unit, Cambridge, England
- Eric Kandel, Columbia University
- Nikos Logothetis, Max-Planck Institute
- Carla Shatz, Harvard Medical School
- Charles Stevens, Salk Institute
- Robert Wurtz, National Institutes of Health
Leadership Board
- James Poitras, Board Chairman, President and CEO, Highland Laboratories, Inc.
- Tenley E. Albright, M.D., Director, Collaborative Initiatives at MIT
- Gerald Burnett, Ph.D., CEO, Avistar Communications Corporation
- Robert M. Buxton, Executive Vice President Peter Kimmelman Asset Management LLC
- Eric Cosman, Ph.D., President, Cosman Company Inc.
- Nicholas Covatta, Chairman, Atlantis Group Inc.
- Mark Gorenberg, Partner, Hummer Winblad Venture Partners
- Perry Ha, Managing Director, Athena Technology Ventures
- Kenneth Kaplan, Associate Director, Urban Design Laboratory Earth Institute, Columbia University
- Zack Lynch, Managing Director, NeuroInsights
- Robert Metcalfe, Ph.D., General Partner, Polaris Venture Partners
- Jane Pauley, Broadcast Journalist, Author
- Thomas F. Peterson, Jr., Inventor, Entrepreneur, Philanthropist
- Patricia Poitras, President, Poitras Charitable Foundation, Inc.
- Sheldon Razin, Chairman of the Board, Quality Systems, Inc.
- David W. Summa, President and CEO, Acumen Pharmaceuticals
- Nancy Wexler, Ph.D., President, Hereditary Disease Foundation and Higgins Professor of Neuropsychology, Columbia University
Friends of the Institute
- David Bleakman
- Kelly and Elizabeth Conlin
- Robert and Patricia Dettmer
- Robert Farmer
- Michael and Judith Gaulke
- George Green and Wilma Jordan
- Richard Hargreaves
- Ann Kaplan
- Harvey Kaufman
- Angus MacDonald
- Paul Marcus
- Michael Norkus
- Tom and Regina Pyle
- Carolyn Ring
- Sandy and Jeanne Robertson
- Carina Ryan
- Roger Sametz
- Hugo Shong
- Susan Stautberg
- Ira and Alice Steinman
- Kathryn Swintek
- George and Amanda Sykes
- George and Linda Sykes
- Richard Vancil
|
